中国的风险因素归因于癌症负担的三十年趋势:来自2023年全球疾病负担研究的见解
Fuliang Cai1, Hengqiong Gu2, Fajun Li1
1Department of Critical Care Medicine, The First People's Hospital of Kunshan, Kunshan, Jiangsu Province.
概括
从1990年到2023年,中国的癌症死亡人数从1990年到2023年增加了74%,主要原因是烟草和肥胖率上升等行为风险. 尽管年龄标准化率下降,但绝对癌症负担需要更强有力的公共卫生干预措施.
科学领域:
- 公共卫生 公共卫生
- 流行病学 流行病学
- 癌症研究 癌症研究
背景情况:
- 癌症是中国的一个重大公共卫生问题.
- 可修改的风险因素对癌症负担作出了重大贡献.
- 关于长期,层次风险趋势的数据有限.
研究的目的:
- 评估从1990年到2023年,中国的风险因素所造成的癌症负担.
- 分析癌症负担的时间,性别和年龄特定模式.
- 量化不同风险因素类别的比较效应大小.
主要方法:
- 利用了2023年全球疾病负担研究的数据.
- 分析了癌症死亡率,残疾调整寿命年 (DALYs) 和年龄标准化率 (ASDR).
- 检查的风险因素分为行为,代谢和环境/职业等级.
主要成果:
- 从1990年到2023年,由于危险因素导致的癌症死亡人数增加了74.1% (至128万).
- 行为风险构成了最大的负担;烟草是主要因素,高BMI显示最急剧的增长.
- 气管,支气管和肺癌的ASDR风险最高;男性的死亡率和DALY率更高.
结论:
- 风险因子归因于癌症的绝对负担不断增加,需要引起注意.
- 加强对烟草的控制是至关重要的.
- 预防肥胖和环境健康干预措施是必要的.
相关概念视频
Cancer Prevention
7.6K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
7.6K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Cancer Survival Analysis
645
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
645
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
397
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
397
Hazard Ratio
558
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
558
Prevalence and Incidence
1.5K
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
1.5K


